http://money.ninemsn.com.au/article.aspx?id=719567"ABN Amro...

  1. 1,546 Posts.
    lightbulb Created with Sketch. 5
    http://money.ninemsn.com.au/article.aspx?id=719567

    "ABN Amro rates as Buy - The broker notes that while US market penetration of the company's lead product Evamist is slower than anticipated, it is still trending upwards. Otherwise, the broker expects a licensing deal for Ellavie outside of the US by the end of FY09 and finalisation of recruitment of a Phase III trial for Tesosterone MD-Lotion. Lower earnings see FY09-10 EPS forecasts cut by 18.5% and 28.8%, which sees the target price drop to $1.09 (from A$2.05), but otherwise the Buy is maintained."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $6.524M
Open High Low Value Volume
1.5¢ 1.6¢ 1.5¢ $9.887K 624.5K

Buyers (Bids)

No. Vol. Price($)
1 6355 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 20000 1
View Market Depth
Last trade - 15.00pm 26/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.